Compare ORMP & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORMP | MRBK |
|---|---|---|
| Founded | 2002 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.6M | 227.2M |
| IPO Year | 2010 | 2018 |
| Metric | ORMP | MRBK |
|---|---|---|
| Price | $4.20 | $18.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 151.9K | 54.6K |
| Earning Date | 11-12-2026 | 10-26-2026 |
| Dividend Yield | ★ 6.00% | 3.01% |
| EPS Growth | ★ 412.50 | 30.34 |
| EPS | ★ 2.76 | 0.64 |
| Revenue | $2,000,000.00 | ★ $6,316,000.00 |
| Revenue This Year | N/A | $2.31 |
| Revenue Next Year | N/A | $7.89 |
| P/E Ratio | ★ $1.51 | $29.03 |
| Revenue Growth | ★ 49.25 | 10.13 |
| 52 Week Low | $2.09 | $13.81 |
| 52 Week High | $5.47 | $21.59 |
| Indicator | ORMP | MRBK |
|---|---|---|
| Relative Strength Index (RSI) | 35.04 | 32.83 |
| Support Level | $4.16 | $18.42 |
| Resistance Level | $4.22 | $20.63 |
| Average True Range (ATR) | 0.15 | 0.46 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 10.26 | 4.51 |
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.